Omeros Gross Margin 2010-2024 | OMER

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Omeros gross margin from 2010 to 2024. Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

Omeros Gross Margin 2010-2024 | OMER

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Omeros gross margin from 2010 to 2024. Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$198.6B
Stryker (SYK)	$139.1B
Boston Scientific (BSX)	$123.3B
Medtronic (MDT)	$114.7B
EssilorLuxottica (ESLOY)	$106.1B
Haleon (HLN)	$47.7B
Lonza Group Ag (LZAGY)	$46.2B
ResMed (RMD)	$35.7B
Koninklijke Philips (PHG)	$29.1B
Terumo (TRUMY)	$28.6B
Zimmer Biomet Holdings (ZBH)	$21.7B
Baxter (BAX)	$19.8B
Insulet (PODD)	$16.7B
Smith & Nephew SNATS (SNN)	$13.5B
Bio-Rad Laboratories (BIO)	$9.6B
Demant (WILYY)	$9.2B
BellRing Brands (BRBR)	$7.7B
Lantheus Holdings (LNTH)	$7.5B
ICU Medical (ICUI)	$4.4B
TG Therapeutics (TGTX)	$3.9B
Haemonetics (HAE)	$3.8B
Neogen (NEOG)	$3.8B
Perrigo (PRGO)	$3.8B
GN Store Nord (GNNDY)	$3.7B
Prestige Consumer Healthcare (PBH)	$3.7B
Envista Holdings (NVST)	$3.3B
QuidelOrtho (QDEL)	$3.1B
Agios Pharmaceuticals (AGIO)	$2.7B
Maravai LifeSciences Holdings (MRVI)	$2.2B
Green Thumb Industries (GTBIF)	$2.2B